Full text

Turn on search term navigation

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Background: Until recently, advanced HCC patients with major vessel and cardiac involvement have had an extremely poor prognosis without satisfactory treatment. Case presentation: A 63-year-old Taiwanese male presented with metastatic HCC with RA and IVC thrombi, as well as pulmonary metastases that were successfully treated by multimodal management, encompassed by surgical thrombectomy, concurrent systemic sorafenib and locoregional therapies, and immunotherapy. The patient has achieved a complete response over the past 33 months. Conclusions: Through this case report, which shows a successful outcome via multimodal management, a more aggressive approach should be considered when a patient is expected to tolerate the risks and side effects of various treatments.

Details

Title
Complete Response in Metastatic Hepatocellular Carcinoma with Cardiac and Lung Involvement via Multimodality Treatment
Author
Kun-Feng Tsai 1 ; Tsai, Jerry C H 2   VIAFID ORCID Logo  ; Ming-Feng, Li 3   VIAFID ORCID Logo  ; Tan, Jimmy W H 4 ; Chu-Kuang Chou 5   VIAFID ORCID Logo  ; Huei-Lung Liang 3 ; Shan-Ho, Chan 6 

 Gastroenterology and Hepatology Section, Department of Internal Medicine, An Nan Hospital, China Medical University, Tainan 709, Taiwan; [email protected]; Department of Medical Sciences Industry, Chang Jung Christian University, Tainan 711, Taiwan 
 Department of Radiology, New Taipei City Hospital-Sanchong Branch, New Taipei City 241, Taiwan; [email protected] 
 Department of Radiology, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan; [email protected]; Department of Medical Imaging and Radiology, Shu-Zen Junior College of Medicine and Management, Kaohsiung 821, Taiwan; [email protected] 
 Division of Cardiovascular Surgery, An Nan Hospital, China Medical University, Tainan 709, Taiwan; [email protected] 
 Division of Gastroenterology and Hepatology and Clinical Trial Center, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi 600, Taiwan; [email protected] 
 Department of Medical Imaging and Radiology, Shu-Zen Junior College of Medicine and Management, Kaohsiung 821, Taiwan; [email protected] 
First page
849
Publication year
2021
Publication date
2021
Publisher
MDPI AG
ISSN
1010660X
e-ISSN
16489144
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2565382872
Copyright
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.